Data for Effect of Mirabegron Treatment on serum lipidome (Study ST001215)

(Analysis AN002026)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2
10-HDHA 1.2573 0.7105
11,12-diHETrE 0.9149 1.0851
11(12)-EET 0.9284 1.2149
11-beta-PGF2a/PGF2b 1.0684 0.9316
11-dehydro TxB2 0.9607 1.0786
11-HDHA 1.3122 0.6358
11-HEPE 1.1217 0.8630
11-HETE 1.2709 0.7291
12,13-diHOME 0.9324 1.0676
12(13)-EpOME 1.0602 0.9398
12-HEPE 1.5501 0.3124
12-HETE 1.2188 0.7812
12-oxoETE 1.2825 0.3408
12-oxoLTB4 1.2300 0.4250
13,14-dihydro-15-keto PGA2 1.0253 0.9578
13,14-dihydro-15-keto PGD2 1.0600 0.9250
13,14-dihydro-15-keto PGE2 1.4092 0.6727
13,14-dihydro-15-keto PGF2a 0.7255 1.2745
13,14-dihydro PGE1 1.0285 0.9715
13-HDHA 1.1270 0.9093
13-HODE 1.1132 0.8868
13-HOTrE/13-HOTrE(r) 1.0484 0.9516
13-oxoODE 1.1118 0.8882
14,15-diHETE 1.1034 0.8819
14,15-diHETrE 0.8555 1.1445
14(15)-EET 1.1399 0.8729
14(15)-EpETE 1.1408 0.7536
14-HDHA 1.3872 0.5698
15-deoxy-delta12,14-PGD2 0.7961 1.2549
15-deoxy-delta12,14-PGJ2 1.0893 0.9196
15-HEPE 0.9272 1.0624
15-HETE 1.0286 0.9685
15-HETrE 1.0471 0.9529
15-keto-PGE2 1.0000 NA
15-keto-PGF2a 1.1461 0.9269
15-oxoETE 1.0499 0.9501
16(17)-EpDPE 1.0116 0.9870
16-HDHA 0.8126 1.2498
16-HETE 0.9140 1.0860
17,18-diHETE 0.9764 1.0236
17(18)-EpETE 1.2542 0.8729
17-HDHA 0.7491 1.2788
17-HETE 1.2805 0.7450
18-HEPE 0.8489 1.1133
18-HETE 1.0301 0.9781
19,20-diHDPA 0.8661 1.1339
19(20)-EpDPE 1.1411 0.8871
19/20-OH PGE2 1.0659 0.9561
19/20-OH PGF2a 1.0924 0.8984
20-carboxy LTB4 1.0000 NA
20-HDHA 1.2053 0.5895
20-HETE 1.3005 0.7541
2,3-dinor-11beta-PGF2a 1.1356 0.7288
2,3-dinor TxB2 0.9230 1.1540
4-HDHA 1.2033 0.6272
5,15-diHETE 1.0935 0.9065
5,6-diHETE 0.5086 1.6879
5,6-diHETrE 1.0185 0.9852
5(6)-EET 1.0000 NA
5-HEPE 1.0947 0.9148
5-HETE 0.9455 1.0545
5-HETrE 0.9116 1.0796
5-iPF2a-VI 0.9313 1.0687
5-oxoETE 1.0564 0.9507
6,15-diketo-13,14-dihydro PGF1a 0.9068 1.0233
6-keto PGE1 0.9328 1.0480
6-keto-PGF1a 0.9437 1.0643
7-HDHA 1.0480 0.9712
8,9-diHETrE 0.8211 1.1789
8(9)-EET 0.3593 1.2136
8-HDHA 1.0650 0.9164
8-HEPE 0.9616 1.0461
8-HETE 1.1250 0.8472
8-HETrE 0.9773 1.0249
8-iso PGF2a 0.8764 1.1544
9,10-diHOME 0.9839 1.0161
9(10)-EpOME 1.1039 0.8961
9-HEPE 1.1666 0.8889
9-HETE 1.1339 0.8513
9-HODE 1.0539 0.9461
9-HOTrE 1.1372 0.8628
9-oxoODE 1.0643 0.9357
Bicyclo PGE2 0.9919 1.0129
d4-9-HODE NA NA
d4-LTB4 NA NA
d4-PGE2 NA NA
d8-5S-HETE NA NA
delta12-PGJ2 1.1086 0.9069
Hepoxilin A3 0.3761 1.9983
LTB4 1.0614 0.9078
LTC4 NA 1.0000
LTD4 1.0282 0.9577
LTE4 1.0000 NA
LXA4 0.8625 1.1833
LXB4 1.2847 0.9288
Maresin1 NA NA
PD1 1.5543 0.7228
PGA1 0.8899 1.1468
PGA2/PGJ2 1.0976 0.8862
PGB2 1.1477 0.8523
PGD2 1.0656 0.9181
PGD3/PGE3 1.2573 0.5711
PGE1/PGD1 1.0200 0.9700
PGE2/PGD2 1.2066 0.7727
PGF1a 1.0609 0.9391
PGF2a 1.1367 0.8438
PGK2 1.0057 0.9924
RvD1 1.1609 0.5978
RvD2 1.1848 0.8152
Tetranor-12-HETE 1.0878 0.9122
tetranor-PGFM 1.0871 0.9303
TxB2 1.1726 0.8274
TxB3 0.9657 1.0549
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Treatment:Mirabegron
F2Treatment:Placebo
  logo